Fouremm, thanks for letting us know that "RVX will announce trial in full detail on Oct 21st on clinicaltrials.gov." Coincidentally, Resverlogix is a presenting company at the BIO Investor Forum in San Francisco October 20-21. I'm not sure if this is enrollment launch or beginning of dosing. I thought Don had said in the past that the trial details would be listed on ClinicalTrials.gov at the start of dosing; however in the R&R presentation on 9/10/15 DM said a short few weeks from starting enrollment. I like to think of a few as in the 3-6 range. So 6 weeks from 9/10 is right around 10/21.

BDAZ